PRSS50 and breast carcinoma: By upregulating the expression of these BCSC factors, TSP50 promoted the formation capacity of primary and secondary mammospheres, increased the level of colony formation and ADR drug resistance, and enhanced the tumorigenicity of breast cancer cells.